Search results
Sep 6, 2018 · The company lured FDA official Wellington Sun, M.D., to help discover new candidates and advance existing programs. Sun will take the position of head of vaccine strategy and regulatory affairs...
- Eric Sagonowsky
View Wellington Sun, M.D.’s profile on LinkedIn, a professional community of 1 billion members. Infectious disease physician-scientist with diverse expertise in medicine, science…
- 485
- Vaxcellerant LLC
- 507
CAMBRIDGE, Mass., September 05, 2018 — Moderna, Inc., a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that Dr. Wellington Sun will join the company as its Head, Vaccine Strategy and Regulatory Affairs, starting ...
Wellington SUN | Cited by 4,675 | of Moderna, Cambridge (MODERNA) | Read 57 publications | Contact Wellington SUN
Sep 15, 2018 · Moderna reported that Dr. Wellington Sun will join the company as its Head, Vaccine Strategy and Regulatory Affairs, starting later this month. Dr. Sun comes to Moderna from the U.S. Food and Drug...
Jan 1, 2022 · Wellington Sun, MD, of Vaxcellerant LLC, an expert in infectious disease and vaccine research and development, presented a "Primer of COVID-19 vaccines for the perioperative physician." Operation Warp Speed was successful in producing multiple efficacious and safe vaccines for use in the United States and around the globe.
Dr Wellington Sun - The meeting place for vaccine professionals from industry, academia, non-profit organizations and government to discuss challenges and successes.
